Welcome to LookChem.com Sign In|Join Free
  • or
Home > Products >  > 

Psilocybin

Related Products

Hot Products

This product is a nationally controlled contraband, and the Lookchem platform doesn't provide relevant sales information.
Name

Psilocybin

EINECS 208-294-4
CAS No. 520-52-5 Density 1.409g/cm3
PSA 95.60000 LogP 1.74350
Solubility N/A Melting Point 220-2280C
Formula C12H17 N2 O4 P Boiling Point 523.4°Cat760mmHg
Molecular Weight 284.252 Flash Point 270.4°C
Transport Information N/A Appearance N/A
Safety Poison by intravenous route. Moderately toxic by intraperitoneal route. Human systemic effects by ingestion and intraperitoneal routes: euphoria, hallucinations, toxic psychosis, muscle weakness, nausea or vomiting, visual field changes. Mutation data reported. When heated to decomposition it emits very toxic fumes of NOx and POx. Risk Codes N/A
Molecular Structure Molecular Structure of 520-52-5 (psilocybine) Hazard Symbols N/A
Synonyms

1H-Indol-4-ol,3-[2-(dimethylamino)ethyl]-, dihydrogen phosphate (ester) (9CI);Indol-4-ol,3-(2-dimethylaminoethyl)-, phosphate (6CI);Indol-4-ol,3-[2-(dimethylamino)ethyl]-, dihydrogen phosphate (ester) (8CI);3-(2-Dimethylaminoethyl)indol-4-yl dihydrogen phosphate;4-Phosphoryl-N,N-dimethyltryptamine;Cy 39;Indocybin;O-Phosphoryl-4-hydroxy-N,N-dimethyltryptamine;Psilocine phosphate;Psilocybin;Psilocybine;Psylocybin;

Article Data 10

Psilocybin Consensus Reports

EPA Genetic Toxicology Program.

Psilocybin Specification

 The Psilocybine, with the CAS registry number 520-52-5,is also known as 3-(2-(Dimethylamino)ethyl)-1H-indol-4-ol dihydrogen phosphate ester. It belongs to the product categories of Intermediates & Fine Chemicals;Pharmaceuticals.This chemical's molecular formula is C12H17N2O4P and molecular weight is 284.25. What's more,Its systematic name is Psilocybine.It is Crystallin Solid ,which is the major of two hallucinogenic components of Teonanacatl, the sacred mushroom of Mexico, the other component being psilocin.

Physical properties about Psilocybine are:
(1)ACD/LogP:  0.72; (2)# of Rule of 5 Violations:  0; (3)ACD/LogD (pH 5.5):  -1.78; (4)ACD/LogD (pH 7.4):  -1.95; (5)ACD/BCF (pH 5.5):  1.00; (6)ACD/BCF (pH 7.4):  1.00; (7)ACD/KOC (pH 5.5):  1.00; (8)ACD/KOC (pH 7.4):  1.00; (9)#H bond acceptors:  6; (10)#H bond donors:  3; (11)#Freely Rotating Bonds:  5; (12)Index of Refraction:  1.645; (13)Molar Refractivity:  73.054 cm3; (14)Molar Volume:  201.61 cm3; (15)Surface Tension:  66.1719970703125 dyne/cm; (16)Density:  1.41 g/cm3; (17)Flash Point:  270.369 °C; (18)Enthalpy of Vaporization:  83.913 kJ/mol; (19)Boiling Point:  523.443 °C at 760 mmHg; (20)Vapour Pressure:  0 mmHg at 25°C.

You can still convert the following datas into molecular structure:
(1)SMILES:O=P(O)(O)Oc1cccc2c1c(cn2)CCN(C)C;
(2)Std. InChI:InChI=1S/C12H17N2O4P/c1-14(2)7-6-9-8-13-10-4-3-5-11(12(9)10)18-19(15,16)17/h3-5,8,13H,6-7H2,1-2H3,(H2,15,16,17);
(3)Std. InChIKey:QVDSEJDULKLHCG-UHFFFAOYSA-N.

Safety Information of Psilocybine:
Poison by intravenous route. Moderately toxic by intraperitoneal route. Human systemic effects by ingestion and intraperitoneal routes: euphoria, hallucinations, toxic psychosis, muscle weakness, nausea or vomiting, visual field changes. Mutation data reported. When heated to decomposition it emits very toxic fumes of NOx and POx.

The toxicity data of Psilocybine as follows:

Organism Test Type Route Reported Dose (Normalized Dose) Effect Source
human TDLo intramuscular 75ug/kg (0.075mg/kg) BEHAVIORAL: EUPHORIA

BEHAVIORAL: "HALLUCINATIONS, DISTORTED PERCEPTIONS"
Psychopharmacologia Vol. 3, Pg. 219, 1962.
human TDLo intramuscular 130ug/kg (0.13mg/kg) BEHAVIORAL: "HALLUCINATIONS, DISTORTED PERCEPTIONS"

BEHAVIORAL: TOXIC PSYCHOSIS
Proceedings of the European Society for the Study of Drug Toxicity. Vol. 8, Pg. 59, 1967.
human TDLo intraperitoneal 37ug/kg (0.037mg/kg) SENSE ORGANS AND SPECIAL SENSES: VISUAL FIELD CHANGES: EYE

BEHAVIORAL: MUSCLE WEAKNESS

GASTROINTESTINAL: NAUSEA OR VOMITING
Journal of Nervous and Mental Disease. Vol. 131, Pg. 428, 1960.
human TDLo oral 60ug/kg (0.06mg/kg) SENSE ORGANS AND SPECIAL SENSES: VISUAL FIELD CHANGES: EYE

BEHAVIORAL: MUSCLE WEAKNESS

GASTROINTESTINAL: NAUSEA OR VOMITING
Journal of Nervous and Mental Disease. Vol. 131, Pg. 428, 1960.
mouse LD50 intraperitoneal 420mg/kg (420mg/kg) SENSE ORGANS AND SPECIAL SENSES: MYDRIASIS (PUPILLARY DILATION): EYE

GASTROINTESTINAL: CHANGES IN STRUCTURE OR FUNCTION OF SALIVARY GLANDS

BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD
Nippon Yakurigaku Zasshi. Japanese Journal of Pharmacology. Vol. 64, Pg. 159, 1968.
mouse LD50 intravenous 275mg/kg (275mg/kg) SENSE ORGANS AND SPECIAL SENSES: MYDRIASIS (PUPILLARY DILATION): EYE

BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD

GASTROINTESTINAL: CHANGES IN STRUCTURE OR FUNCTION OF SALIVARY GLANDS
Nippon Yakurigaku Zasshi. Japanese Journal of Pharmacology. Vol. 64, Pg. 159, 1968.
rabbit LD50 intravenous 13mg/kg (13mg/kg)   "Psychotropic Drugs and Related Compounds," 2nd ed., Usdin, E., and D.H. Efron, Washington, DC, 1972Vol. -, Pg. 138, 1972.
rat LD50 intravenous 280mg/kg (280mg/kg)   "Psychotropic Drugs and Related Compounds," 2nd ed., Usdin, E., and D.H. Efron, Washington, DC, 1972Vol. -, Pg. 138, 1972.